Cellectis
CLLS
90 hedge funds and large institutions have $463M invested in Cellectis in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 13 closing their positions.
131% more call options, than puts
Call options by funds: $2.32M | Put options by funds: $1M
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
79% more capital invested
Capital invested by funds: $259M → $463M (+$204M)
22% more funds holding
Funds holding: 74 → 90 (+16)
4.99% more ownership
Funds ownership: 33.6% → 38.59% (+5%)
4% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 24
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$57.1M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$11.2M |
| 3 |
Jane Street
New York
|
+$3.16M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$2.55M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$2.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.5M |
| 2 |
Millennium Management
New York
|
-$6.59M |
| 3 |
Morgan Stanley
New York
|
-$4.84M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$3.43M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$3.09M |
CLLS Hedge Fund Activity: Q4 2020 in Review
90 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2020, worth a combined $463M — up 79% from $259M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new CLLS positions and 13 closed out — a net gain of 17 holders — while 25 added to existing stakes and 24 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $57.1M. The largest seller was Fidelity Investments, cutting an estimated $10.5M.
- 90 institutional investors held Cellectis (CLLS) as of Q4 2020, up from 74 in Q3 2020.
- Funds reported $463M of Cellectis stock for Q4 2020, up 79% quarter-over-quarter.
- 30 funds opened new Cellectis positions in Q4 2020 and 13 closed out, a net change of +17 holders.
- The largest Cellectis buyer in Q4 2020 was ARK Investment Management, an estimated $57.1M added.
- The largest Cellectis seller in Q4 2020 was Fidelity Investments, an estimated $10.5M sold.
Based on aggregated 13F filings for Q4 2020.